908 Devices (MASS) Stock Price, News & Analysis

Company Overview

908 Devices Inc (NASDAQ: MASS) is a developer and manufacturer of portable analytical instruments designed to deliver rapid chemical detection in field and laboratory environments. The company’s core focus lies in miniaturizing high-performance mass spectrometry and ion mobility spectrometry technologies, enabling users to perform on-site analysis that traditionally required benchtop equipment.

Key products in 908 Devices’ portfolio include the MX908, a handheld high-resolution mass spectrometer capable of detecting and identifying a broad range of chemicals and explosives; the M908 portable mass spectrometer for laboratory or mobile units; and the ZipChip capillary electrophoresis system for high-throughput, microfluidic separations. These platforms are designed to offer fast sample-to-answer workflows with integrated data analysis software.

Founded in 2004 and headquartered in Boston, Massachusetts, 908 Devices leverages its proprietary micro-engineering and analytical expertise to serve customers around the world. The company’s instruments are employed across North America, Europe, Asia and other regions through a combination of direct sales, channel partners and strategic alliances.

The company’s solutions support a variety of applications, including security and defense screening, forensic investigations, environmental monitoring, pharmaceutical quality control and food safety testing. By providing real-time chemical intelligence at the point of need, 908 Devices aims to enhance operational efficiency and safety for government agencies, research institutions and commercial laboratories.

Key Stats

• Today's Range: $8.36 to $9.00
• 50-Day Range: $5.75 to $8.93
• 52-Week Range: $5.03 to $9.34
• Volume: 175,011 shs
• Average Volume: 295,917 shs
• Market Capitalization: $324.41 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $12.00
• Consensus Rating: Hold

908 Devices Stock Analysis - MarketRank™

908 Devices scored higher than 46% of companies evaluated by MarketBeat, and ranked 647th out of 871 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.2 / 5
• Analyst Rating: Hold

Consensus Rating

908 Devices has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

908 Devices has a consensus price target of $12.00, representing about 35.7% upside from its current price of $8.85.

Amount of Analyst Coverage

908 Devices has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for 908 Devices are expected to grow in the coming year, from ($0.38) to ($0.30) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of 908 Devices is -8.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of 908 Devices is -8.91, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

908 Devices has a P/B Ratio of 2.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

12.31% of the float of 908 Devices has been sold short.

Short Interest Ratio / Days to Cover

908 Devices has a short interest ratio ("days to cover") of 10.57, which indicates bearish sentiment.

Change versus previous month

Short interest in 908 Devices has recently decreased by 3.88%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

908 Devices does not currently pay a dividend.

Dividend Growth

908 Devices does not have a long track record of dividend growth.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 1.71

News Sentiment

908 Devices has a news sentiment score of 1.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.80 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 2 news articles for 908 Devices this week, compared to 3 articles on an average week.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, 908 Devices insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $668,032.00 in company stock.

Percentage Held by Insiders

28.20% of the stock of 908 Devices is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

88.06% of the stock of 908 Devices is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 3/03/2026
• Today: 5/29/2026
• 16th Annual East Coast IDEAS Conference: 6/10/2026
• Next Earnings (Estimated): 8/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Measuring And Control Equipment
• Current Symbol: NASDAQ:MASS
• CIK: 1555279
• Web: www.908devices.com
• Phone: 857-254-1500
• Fax: N/A
• Employees: 60
• Year Founded: 2012

Price Target and Rating

• Average Price Target for 908 Devices: $12.00
• High Price Target: $12.00
• Low Price Target: $12.00
• Potential Upside/Downside: +40.7%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.00)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $19.49 million
• Net Margins: -62.40%
• Pretax Margin: -61.35%
• Return on Equity: -14.03%
• Return on Assets: -10.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.58
• Quick Ratio: 3.25

Sales & Book Value

• Annual Sales: $56.20 million
• Price / Sales: 5.74
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $3.55 per share
• Price / Book: 2.40

Miscellaneous

• Outstanding Shares: 37,810,000
• Free Float: 27,150,000
• Market Cap: $322.56 million
• Optionable: Optionable
• Beta: 0.57